CMI_LatestReportOrientedBlogs

  Surgical Lasers Surgical lasers, rather than surgical implements like a knife, employ specific light beams to execute surgical procedures. During surgery, many types of lasers are employed, each with its own set of purposes. Laser light can be administered constantly or intermittently, and it can be used with fibre optics to treat hard-to-reach parts of the body. Laser surgery is less intrusive and has the benefit of lowering infection risk and promoting rapid recovery. The global Surgical Lasers Market size was valued at US$ 1.4 billion in 2017 and is expected to witness a CAGR of 5.4% over the forecast period (2018 – 2026). To cure cancer and other disorders, laser treatment employs high-intensity light. These can be used to decrease or kill tumours or precancerous growths, as well as to treat superficial malignancies like basal cell skin cancer and the early stages of cancers including cervical, penile, vaginal, vulvar, and non-small cell lung cancer. The most common lasers use

  The next big hope in the fight against advanced cancers lies with Anti-body Coupled T Receptor Therapy . This technology combines genetic engineering with traditional therapy to create an efficient new cancer fighting agent. There are at least ten types of receptor therapies in the anti-cancer market, with an additional four developing over the next few years. Most of them involve using antibodies to target specific cancer cells, such as leukemia or melanoma. Others involve injecting antibodies directly into a tumor or a cancerous site to kill the root cause. One new class of drugs called systemic antigens is being developed for this purpose. These may provide the basis for a new anti-cellulite, anti-thrombotic, and anti-viral class of drugs in the future. For instance, in August 2021, Salipro Biotech partnered with the European Molecular Biology Laboratory, Germany to explore the efficacy of Salipro solutions in mAb (monoclonal antibody) discovery. The company has conducted studies

  Alveolar Rhabdomyosarcoma Treatment often includes surgery, chemotherapy, and radiation therapy (radiotherapy). Moreover, the treatment of rhabdomyosarcoma has greatly improved the care of patients over the past few decades. Around 80% of patients with rhabdomyosarcoma (low-risk) can now be cured. Alveolar rhabdomyosarcoma (ARMS) refers to one subtype of the rhabdomyosarcoma family of soft tissue tumors. While, rhabdomyosarcoma is a rare type of cancer that forms in soft tissue; may occur at any age, often affects children. Alveolar Rhabdomyosarcoma Treatment , such as chemotherapy, is given by injection into a vein. In North America, drugs such as cyclophosphamide (Neosar, Clafen, Cytoxan,), dactinomycin (Cosmegen, Lyovac Cosmegen), and vincristine (Vincasar, Oncovin) are commonly used to treat rhabdomyosarcoma. This combination of drugs is often called Vincristine, actinomycin D, and cyclophosphamide (VAC), an abbreviation for a chemotherapy combination used to treat rhabdomyosarc

  Retractable Needle Safety Syringes are designed to provide patients with a painless way to receive their IV fluids, doctors typically prefer to use manual devices over the ones manufactured using disposable materials. Technological advances allowed manufacturers to create devices that were suitable for administering pain-managed medication such as oxycodone. Today, however, many health care professionals are recommending these products due to their effectiveness. These products are now frequently used by physicians treating patients with chronic conditions such as cancer, diabetes, and multiple sclerosis. Although these devices still carry some risk, many experts now agree that they are an acceptable alternative to the traditional rabbit syringes and other types of injectable devices. For instance, in August 2021, an Indian medical equipment making company, Hindustan Syringes & Medical Devices Limited, reached a milestone of producing over 1 billion AD syringes for COVID-19 vacc